Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.
- NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_assertion description "[Although IFG fully inhibits GlcCerase in the lysosome in an in situ assay, washout of the drug leads to partial recovery of GlcCerase activity within 4 h and full recovery by 24 h. These findings provide support for the possible use of active-site inhibitors in the treatment of some forms of Gaucher disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.
- NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_assertion evidence source_evidence_literature NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.
- NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_assertion SIO_000772 16945909 NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.
- NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_assertion wasDerivedFrom befree-2016 NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.
- NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_assertion wasGeneratedBy ECO_0000203 NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.
- befree-2016 importedOn "2016-02-19" NP566960.RASx_GHcTab3A5Prc_c_dzu9iAhN7YVZfzBwtFOPj_Ses130_provenance.